Unexpected unrelated umbilical cord blood stem cell engraft in two patients with severe aplastic anemia that received immunosuppressive treatment: A case report and literature review

Xie,Lin‑Na; Zhou,Fang

doi:10.3892/etm.2015.2698

Unexpected unrelated umbilical cord blood stem cell engraft in two patients with severe aplastic anemia that received immunosuppressive treatment: A case report and literature review

Authors:
- Lin‑Na Xie
- Fang Zhou
View Affiliations

Affiliations: Department of Hematology, The General Hospital of Jinan Military, Jinan, Shandong 250031, P.R. China
Published online on: August 21, 2015 https://doi.org/10.3892/etm.2015.2698
Pages: 1563-1565

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Severe aplastic anemia (SAA) is a life-threatening bone marrow disorder. Bone marrow transplantation is the primary therapy for SAA; however, its efficacy is limited by numerous factors, including lack of histocompatible sibling donor, patient age and graft‑versus‑host‑disease (GVHD) following transplantation. Immunosuppressive treatment (IST) is the first procedure developed for patients without a sibling donor. Our previous study reported that patients administered enhanced IST, in addition to a regime of unrelated umbilical cord blood (UCB) transfusion, exhibited higher efficiency and a reduced rate of relapse. Therefore, the present study reported the cases of 2 patients that received enhanced IST plus unrelated UCB transfusion. These patients exhibited complete hematological recovery with an increased rate of mixed chimerism and demonstrated no signs of GVHD or relapse during the 2‑year follow‑up period. Thus, enhanced immunosuppressive treatment (low‑dose cyclophosphamide and antithymocyte globulin) combined with UCB transfusion may be an effective treatment for patients with SAA.

View Figures

View References

1	Rosenfeld S, Follmann D, Nunez O and Young NS: Antithymocyte globulin and cyclosporine for severe aplastic anemia: Association between hematologic response and long-term outcome. JAMA. 289:1130–1135. 2003. View Article : Google Scholar : PubMed/NCBI
2	Scheinberg P and Young NS: How I treat acquired aplastic anemia. Blood. 120:1185–1196. 2012. View Article : Google Scholar : PubMed/NCBI
3	Peffault de Latour R, Purtill D, Ruggeri A, Sanz G, Michel G, Gandemer V, Maury S, Kurtzberg J, Bonfim C, Aljurf M, et al: Influence of nucleated cell dose on overall survival of unrelated cord blood transplantation for patients with severe acquired aplastic anemia: A study by eurocord and the aplastic anemia working party of the European group for blood and marrow transplantation. Biol Blood Marrow Transplant. 17:78–85. 2011. View Article : Google Scholar : PubMed/NCBI
4	Frickhofen N, Heimpel H, Kaltwasser JP and Schrezenmeier H: German Aplastic Anemia Study Group: Antithymocyte globulin with or without cyclosporin A: 11-year follow-up of a randomized trial comparing treatments of aplastic anemia. Blood. 101:1236–1242. 2003. View Article : Google Scholar : PubMed/NCBI
5	Zhou F, Ge L, Yu Z, Fang Y and Kong F: Clinical observations on intensive immunosuppressive therapy combined with umbilical cord blood support for the treatment of severe aplastic anemia. J Hematol Oncol. 4:272011. View Article : Google Scholar : PubMed/NCBI
6	Scheinberg P: Aplastic anemia. Therapeutic updates in immunosuppression and transplantation. Hematology Am Soc Hematol Educ Program. 2012:292–300. 2012.PubMed/NCBI
7	Marsh J: Making therapeutic decisions in adults with aplastic anemia. Hematology Am Soc Hematol Educ Program. 78–85. 2006. View Article : Google Scholar : PubMed/NCBI
8	Broxmeyer HE, Douglas GW, Hangoc G, Cooper S, Bard J, English D, Arny M, Thomas L and Boyse EA: Human umbilical cord blood as a potential source of transplantable hematopoietic stem/progenitor cells. Proc Natl Acad Sci USA. 86:3828–3832. 1989. View Article : Google Scholar : PubMed/NCBI
9	Gluckman E, Rocha V, Boyer-Chammard A, Locatelli F, Arcese W, Pasquini R, Ortega J, Souillet G, Ferreira E, Laporte JP, et al: Outcome of cord-blood transplantation from related and unrelated donors. Eurocord transplant group and the european blood and marrow transplantation group. N Engl J Med. 337:373–381. 1997. View Article : Google Scholar : PubMed/NCBI
10	MacMillan ML, Walters MC and Gluckman E: Transplant outcomes in bone marrow failure syndromes and hemoglobinopathies. Semin Hematol. 47:37–45. 2010. View Article : Google Scholar : PubMed/NCBI
11	Lee JW, Kang HJ, Kim EK, Shin HY and Ahn HS: Successful salvage unrelated umbilical cord blood transplantation with two units after engraftment failure with single unit in severe aplastic anemia. J Korean Med Sci. 24:744–746. 2009. View Article : Google Scholar : PubMed/NCBI
12	Yoshimi A, Kojima S, Taniguchi S, Hara J, Matsui T, Takahashi Y, Azuma H, Kato K, Nagamura-Inoue T, Kai S and Kato S: Japan Cord Blood Bank Network: Unrelated cord blood transplantation for severe aplastic anemia. Biol Blood Marrow Transplant. 14:1057–1063. 2008. View Article : Google Scholar : PubMed/NCBI
13	Yamamoto H, Kato D, Uchida N, Ishiwata K, Araoka H, Takagi S, Nakano N, Tsuji M, Asano-Mori Y, Matsuno N, et al: Successful sustained engraftment after reduced-intensity umbilical cord blood transplantation for adult patients with severe aplastic anemia. Blood. 117:3240–3242. 2011. View Article : Google Scholar : PubMed/NCBI
14	Sanders JE: Growth and development after hematopoietic cell transplant in children. Bone Marrow Transplant. 41:223–227. 2008. View Article : Google Scholar : PubMed/NCBI
15	Brodsky RA, Chen AR, Dorr D, Fuchs EJ, Huff CA, Luznik L, Smith BD, Matsui WH, Goodman SN, Ambinder RF and Jones RJ: High-dose cyclophosphamide for severe aplastic anemia: Long-term follow-up. Blood. 115:2136–2141. 2010. View Article : Google Scholar : PubMed/NCBI
16	Xie LN, Fang Y, Yu Z, Song NX, Kong FS, Liu XM and Zhou F: Increased immunosuppressive treatment combined with unrelated umbilical cord blood infusion in children with severe aplastic anemia. Cell Immunol. 289:150–154. 2014. View Article : Google Scholar : PubMed/NCBI
17	Boiron JM, Cotterêt S, Cony-Makhoul P, Merel P, Micheau M, Perel Y, Belloc F, Bernard P and Reiffers J: Stable mixed chimerism without relapse after related allogeneic umbilical cord blood transplantation in a child with severe aplastic anemia. Bone Marrow Transplant. 22:819–821. 1998. View Article : Google Scholar : PubMed/NCBI
18	Laughlin MJ, Barker J, Bambach B, Koc ON, Rizzieri DA, Wagner JE, Gerson SL, Lazarus HM, Cairo M, Stevens CE, et al: Hematopoietic engraftment and survival in adult recipients of umbilical-cord blood from unrelated donors. N Engl J Med. 344:1815–1822. 2001. View Article : Google Scholar : PubMed/NCBI